• Je něco špatně v tomto záznamu ?

Detection of mitochondrial DNA variants at low level heteroplasmy in pediatric CNS and extra-CNS solid tumors with three different enrichment methods

K. Kaneva, D. Merkurjev, D. Ostrow, A. Ryutov, P. Triska, K. Stachelek, D. Cobrinik, JA. Biegel, X. Gai

. 2020 ; 51 (-) : 97-103. [pub] 20200120

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21012837

Grantová podpora
R01 CA137124 NCI NIH HHS - United States
T32 CA009659 NCI NIH HHS - United States

The mitochondrial genome is small, 16.5 kb, and yet complex to study due to an abundance of mitochondria in any given cell or tissue. Mitochondrial DNA (mtDNA) mutations have been previously described in cancer, many of which were detected at low heteroplasmy. In this study we enriched the mitochondrial genome in primary pediatric tumors for detection of mtDNA variants. We completed mtDNA enrichment using REPLI-g, Agilent SureSelect, and long-range polymerase chain reaction (LRPCR) followed by next generation sequencing (NGS) on Illumina platforms. Primary tumor and germline genomic DNA from a variety of pediatric central nervous system (CNS) and extra-CNS solid tumors were analyzed by the three different methods. Although all three methods performed equally well for detecting variants at high heteroplasmy or homoplasmy, only LRPCR and SureSelect-based enrichment methods provided consistent results for variants that were present at less than five percent heteroplasmy. We then applied both LRPCR and SureSelect to three successive samples from a patient with multiply-recurrent gliofibroma and detected a low-level novel mutation as well as a change in heteroplasmy levels of a synonymous variant that was correlated with progression of disease. IMPLICATION: This study demonstrates that LRPCR and SureSelect enrichment, but not REPLI-g, followed by NGS are accurate methods for studying the mtDNA variations at low heteroplasmy, which may be applied to studying mtDNA mutations in cancer.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012837
003      
CZ-PrNML
005      
20210507103608.0
007      
ta
008      
210420s2020 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.mito.2020.01.006 $2 doi
035    __
$a (PubMed)31972374
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Kaneva, Kristiyana $u Division of Hematology-Oncology, Neuro-Oncology & Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States. Electronic address: kkaneva@luriechildrens.org
245    10
$a Detection of mitochondrial DNA variants at low level heteroplasmy in pediatric CNS and extra-CNS solid tumors with three different enrichment methods / $c K. Kaneva, D. Merkurjev, D. Ostrow, A. Ryutov, P. Triska, K. Stachelek, D. Cobrinik, JA. Biegel, X. Gai
520    9_
$a The mitochondrial genome is small, 16.5 kb, and yet complex to study due to an abundance of mitochondria in any given cell or tissue. Mitochondrial DNA (mtDNA) mutations have been previously described in cancer, many of which were detected at low heteroplasmy. In this study we enriched the mitochondrial genome in primary pediatric tumors for detection of mtDNA variants. We completed mtDNA enrichment using REPLI-g, Agilent SureSelect, and long-range polymerase chain reaction (LRPCR) followed by next generation sequencing (NGS) on Illumina platforms. Primary tumor and germline genomic DNA from a variety of pediatric central nervous system (CNS) and extra-CNS solid tumors were analyzed by the three different methods. Although all three methods performed equally well for detecting variants at high heteroplasmy or homoplasmy, only LRPCR and SureSelect-based enrichment methods provided consistent results for variants that were present at less than five percent heteroplasmy. We then applied both LRPCR and SureSelect to three successive samples from a patient with multiply-recurrent gliofibroma and detected a low-level novel mutation as well as a change in heteroplasmy levels of a synonymous variant that was correlated with progression of disease. IMPLICATION: This study demonstrates that LRPCR and SureSelect enrichment, but not REPLI-g, followed by NGS are accurate methods for studying the mtDNA variations at low heteroplasmy, which may be applied to studying mtDNA mutations in cancer.
650    _2
$a centrální nervový systém $x patologie $7 D002490
650    _2
$a nádory centrálního nervového systému $x genetika $7 D016543
650    _2
$a mitochondriální DNA $x genetika $7 D004272
650    _2
$a genetická variace $x genetika $7 D014644
650    _2
$a genom mitochondriální $x genetika $7 D054629
650    _2
$a heteroplazmie $x genetika $7 D000081942
650    _2
$a vysoce účinné nukleotidové sekvenování $x metody $7 D059014
650    _2
$a lidé $7 D006801
650    _2
$a mitochondrie $x genetika $7 D008928
650    _2
$a techniky amplifikace nukleových kyselin $x metody $7 D021141
650    _2
$a polymerázová řetězová reakce $x metody $7 D016133
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Merkurjev, Daria $u Department of Pathology Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, CA, United States
700    1_
$a Ostrow, Dejerianne $u Department of Pathology Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, CA, United States
700    1_
$a Ryutov, Alex $u Department of Pathology Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, CA, United States
700    1_
$a Triska, Petr $u Department of Pediatric Hematology and Oncology, Charles University, Prague, United States
700    1_
$a Stachelek, Kevin $u The Vision Center and The Saban Research Institute, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States
700    1_
$a Cobrinik, David $u The Vision Center and The Saban Research Institute, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States
700    1_
$a Biegel, Jaclyn A $u Department of Pathology Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, CA, United States
700    1_
$a Gai, Xiaowu $u Department of Pathology Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, CA, United States
773    0_
$w MED00167280 $t Mitochondrion $x 1872-8278 $g Roč. 51, č. - (2020), s. 97-103
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31972374 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507103607 $b ABA008
999    __
$a ok $b bmc $g 1651081 $s 1133216
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 51 $c - $d 97-103 $e 20200120 $i 1872-8278 $m Mitochondrion $n Mitochondrion $x MED00167280
GRA    __
$a R01 CA137124 $p NCI NIH HHS $2 United States
GRA    __
$a T32 CA009659 $p NCI NIH HHS $2 United States
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace